Aumolertinib in non-small cell lung cancer with uncommon EGFR exon 19 deletions: a real-world dual-center study.

Tagrisso (osimertinib) - AstraZeneca

Ameile (aumolertinib) - Jiangsu Hansoh Pharma

Ivesa (firmonertinib) - Allist, ArriVent

Gilotrif (afatinib) - Boehringer Ingelheim

http://www.ncbi.nlm.nih.gov/pubmed/42071190

Dongsheng He; Fang Wei; Guangjian Yang; Huanbing Qiu; Jiaqi Hu; Linyan Tian; Pei Li; Weihua Li; Xiaoyong Tang; Yan Wang

May 4, 2026